Stem cells

#2024 predictions #Stem cell transplant #Stem cells #Therapeutics

2024 predictions: Experts weigh in on stem cells  

DDW’s Megan Thomas speaks to experts from the drug discovery industry about their predictions on the future of stem cells in drug discovery.   Melissa Little, CEO of the Novo Nordisk Foundation Centre for Stem Cell Medicine  “In the stem cell space, 2023 has seen significant increases in the delivery… Read More

#Exclusive Content

#3D cell culture #ADME / Tox #Cell Science #Organoids #Stem cells

How 3D biology is informing drug discovery

Listen to this article on the DDW Podcast:   DDW Editor Reece Armstrong looks at the advantages and opportunities 3D cell cultures, organoids and stem cells are bringing to drug discovery teams. The use of 2D biology in the pharmaceutical industry has provided researchers with ways to observe how cells… Read More

#Exclusive Content

#Akari Therapeutics #Antibody drug conjugate (ADC) #Mergers and acquisitions #Peak Bio #Stem cells

Akari Therapeutics and Peak Bio announce merger

Biotechnology company Akari Therapeutics and biopharmaceutical company Peak Bio have announced a definitive agreement to merge as equals in an all-stock transaction. The combined entity will operate as Akari Therapeutics, which is expected to continue to be listed and trade on the Nasdaq Capital Market as AKTX. Following closing, the… Read More

#Business & Investment #News

#AI / data analytics / healthtech / informatics #Human disease models #Interview #Neurology #Neuroscience #Stem cells

Putting human data at the centre of drug discovery

Listen to this article on the DDW Podcast: James Peach is the Co-Founder and CEO of Human Centric Drug Discovery (HCDD), an Oxford University spin-out improving neurology drug discovery by bringing more human data to the process. Peach shared his insight with DDW’s Megan Thomas. MT: In what ways can human… Read More

#Exclusive Content #Opinion

Neuron
#ALS #Human disease models #iPSC #Neurology #Pluripotent stem cells #Stem cells #Whitepaper

Whitepaper: Explore iPSC-derived motor neuron morphology

A new whitepaper is now available from DDW and Sartorius entitled ‘iPSC-Derived Motor Neurons and Microglia From ALS Background Display Disease Phenotype’. Induced pluripotent stem cell (iPSC)-derived cells are a significant resource for disease modelling. They allow the use of cells directly from affected patients… Read More

#News

#ALS #Drug discovery #Human disease models #iPSC #Neurology #Pluripotent stem cells #Stem cells

Using patient-specific cells for disease modelling

Induced pluripotent stem cell (iPSC)-derived cells are a significant resource for disease modelling. They allow the use of cells directly from affected patients and have the potential to guide these cells towards multiple lineages. Download the whitepaper to: Explore iPSC-derived motor neuron morphology Discover how ALS disease phenotype… Read More

#Resources

Cells under a microscope
#bit bio #CAR-T #Cell therapy #Interview #iPSC #Stem cells

Scaling up: The need for human cells to give better access to cell therapies

Reece Armstrong speaks to Kathryn Golden, SVP Technical Operations and Manufacturing, bit.bio, about novel technologies, and methods to manufacture human cells for therapies so more patients can access these treatments. Cell therapies have emerged as transformative and potentially curative treatments across a range of disease areas. These therapies, which utilise… Read More

#Exclusive Content

Stem cell transplant
#Cell therapy #Pluripotent stem cells #Regenerative Medicine #Stem cell transplant #Stem cells #University of Arizona

Genetically modified stem cells evade immune rejection

New research has brought stem cell transplantation without immune suppression closer to reality. Researchers at the University of Arizona Health Sciences say they are one step closer to understanding immunological rejection, a barrier to regenerative medicine, after genetically modifying pluripotent stem cells to evade immune recognition. Read More

#Editor's Choice #News

Child having ultrasound on knee
#Arthritis #Australia #Osteoarthritis #Preclinical investigations #Stem cells #University of Adelaide

Study shows osteoarthritis could be reversible

Osteoarthritis may be treatable and reversible, according to a new University of Adelaide study. The researchers have discovered a novel population of stem cells – marked by the Gremlin 1 gene – responsible for the progression of osteoarthritis. Treatment with fibroblast growth factor 18… Read More

#Editor's Choice #News

#Alzheimer's #Cancer research #Cell therapy #CRISPR #Drug discovery #Parkinson's #Plant-based #Stem cells

New DDW Highlights podcast: 4 December 2023

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.  The key drug discovery news this week focuses on experimental approaches to… Read More

#News

#Alzheimer's #Cancer research #Cell therapy #CRISPR #Drug discovery #Parkinson's #Plant-based #Stem cells

This week in drug discovery (27 Nov – 1 Dec) 

News round-up for 27 November – 1 December by DDW Digital Content Editor Diana Spencer. The key drug discovery news this week focuses on experimental approaches to the treatment of some of the most challenging diseases, including a mathematical model that can simulate Alzheimer’s progression and… Read More

#News

Embryonic stem cells
#Cell therapy #Multiple sclerosis #Stem cells #University of Cambridge #University of Colorado #University of Milano-Bicocca

Stem cell therapy shows promise in advanced MS

An international team of scientists has shown that a stem cell therapy for multiple sclerosis (MS) could prevent further damage to the brain. The early-stage clinical trial was the result of a collaboration between researchers at University of Colorado Anschutz Campus, the University of Cambridge and… Read More

#News #Trending News

#Alzheimer's #Drug discovery #Neurology #Stem cells

bit.bio launches stem cell line for neuro research and screening  

Biotechnology company bit.bio has launched a range of immune cells to provide researchers with a consistently functional and rapid human in vitro model for the study of neuroinflammation and neurodegenerative diseases.  The company’s ioMicroglia cell range is designed to recapitulate key human microglia functions and… Read More

#News

Hematopoietic cells
#Cancer research #Clinical trial #Gene therapy #MHRA #Paediatrics #Phase I trial #Stem cells #UK

First gene therapy trial for Hunter syndrome opens in Manchester, UK

UK regulatory authorities have approved the first trial of a gene therapy for young children with Hunter syndrome. The UK Medicines and Healthcare Products Regulatory Agency (MHRA), Research Ethics Committee (REC), and Health Research Authority (HRA) have all approved the clinical trial application that was submitted by The University of… Read More

#Editor's Choice #News #Regulatory

Stem cells
#Human disease models #iPSC #Liver disease #Preclinical investigations #Stem cells #Webinar

Last chance: Discover how iPSC derived cells support drug development

A considerable roadblock in the successful triaging of new therapeutics for liver and metabolic related diseases is the reliability and effectiveness of pre-clinical disease models. Methods employing animal models may have limited success in replicating liver diseases, primarily because of species-specific differences, furthermore, the utilisation of animal models… Read More

Webinar date:
Supported by DefiniGEN
#News

Pluripotent stem cells
#Human disease models #iPSC #Liver disease #Preclinical investigations #Stem cells #Webinar

Register now to discover how iPSC derived cells support gene therapy development

A considerable roadblock in the successful triaging of new therapeutics for liver and metabolic related diseases is the reliability and effectiveness of pre-clinical disease models. Methods employing animal models may have limited success in replicating liver diseases, primarily because of species-specific differences, furthermore, the utilisation of animal models… Read More

Webinar date:
Supported by DefiniGEN
#News